|
Case Report | Age | Sex | Escitalopram Dose | Onset (Days) | Sodium Levels (mEq/L) | Presenting Symptoms | Treatment given | Resolution (Weeks) | Comorbid conditions | Medications | Remarks |
|
Nashoni et al, 2004 [8] | 62 | F | 10 mg | 21 | 110 | Syncope | Medication discontinuation | 1 week | Hypertension, Hyperlipidemia Atrial fibrillation Protein C deficiency Osteoporosis | Losartan Simvastatin Sotalol Warfarin Calcium Vitamin D | Patient was later treated with Mirtazapine for depression |
|
Nirmalani et al, 2006 [22] | 50 | M | 20 mg | 28 | 121 | Weakness Dizziness | Medication discontinuation Fluid Restriction | 5 days | Depression with Psychotic features, Hypertension, COPD Osteoarthritis GERD | Risperidone | |
|
Adiga et al, 2006 [12] | 81 | F | 10 mg | 21 | 120 | Generalized weakness & Recurrent Falls | Medication discontinuation Hypertonic saline | 1 week | Alzheimer's' disease Hypertension Osteoporosis | Ramipril Alendronic acid Donepezil Mirtazapine HCTZ | Patient noted to have Renal tubular defect |
|
Grover et al, 2007 [14] | 67 | F | 10 mg | 28
| 127 | Delirium | Medication discontinuation
| 4 weeks | Bipolar affective disorder Hypertension Diabetes mellitus | Sodium valproate HCTZ Gliclazide Aspirin Losartan | Patient was later treated with Mirtazapine & Valproate for Moderate depression |
|
Grover et al, 2007 [14] | 75 | M | 10 mg | 10 | 126 | Seizures | Medication discontinuation
| 2 weeks | Hypertension Generalized anxiety disorder | Atenolol Amlodipine | Patient was later treated with Mirtazapine for Generalized Anxiety disorder |
|
Covyeou et al, 2007 [13] | 75 | F | Unknown | 5 | 116 | Unknown | Medication discontinuation
| 5 days | Hypertension | Amlodipine HCTZ Aspirin Omeprazole Alprazolam | |
|
Koski et al, 2009 [9] | 97 | F | 5 mg | 7 | 113
| Recurrent Falls & Confusion | Medication discontinuation Fluid restriction Hypertonic saline | Unknown | Hypertension, Anxiety UTI (diagnosed 1 day prior to hospitalization) | Tolterodine Atenolol Furosemide Lisinopril Docusate Ciprofloxacin (started 1 day prior to hospitalization) | |
|
Tsai et al 2012 [11] | 73 | F | 10 mg | >60
| 124 122 | Delirium | Medication discontinuation Fluid restriction | 2 weeks 1 week | Lewy body dementia | Trihexyphenidyl Bethanechol Tamsulosin | Failed rechallenge of escitalopram as patient developed Hyponatremia |
|
Pae et al, 2013 [10] | 47 | M | 5 mg | 2 | 110 | Seizure | Medication discontinuation
| 4 days | Quadriplegia with Spinal A-V Malformation Depression | No other medication
| |
|
Soysal et al, 2014 [23] | 76 | F | 10mg | 28 | 113 | Confusion Lethargy Incontinence | Medication discontinuation Hypertonic saline
| Unknown | Hypertension Diabetes mellitus, Alzheimer’s disease Sleep disorder
| Losartan Sitagliptin Rivastigmine Memantine Trazodone
| |
|
Diken et al, 2016 [15] | 59 | M | 10 mg | 7 | 107 | Confusion, Hallucination, Drowsiness
| Medication discontinuation Fluid restriction Hypertonic saline
| 4 days | COPD Diabetes mellitus
| Aspirin, metoprolol perindopril amiodarone Spironolactone Hydrochlorothiazide
| Recent introduction of hydrochlorothiazide |
|
Parmar et al, 2016 [20] | 50 | M | 10 mg | 3 | 94 | Seizure | Medication discontinuation
| 5 days | Hypertension Panic disorder
| Telmisartan Aspirin | Developed central pontine myelinolysis from rapid correction of sodium |
|
Rawal et al, 2017 [24] | 54 | F | Unknown | 4 | 116 | Seizure | Medication discontinuation Fluid restriction | Unknown | Hypertension Depression | Telmisartan Salt restriction
| |
|
Vidyasagar et al, 2017 [25] | 58 | F | Unknown | 14 | 107 | Severe Constipation | Medication discontinuation High salt diet Fluid restriction | Unknown | Seronegative spondyloarthropathy Diabetes mellitus Dysthymia | Prednisolone, Hydroxychloroquine Methotrexate Insulin | |
|